Northwestern Mutual Wealth Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17 Sell
10
-266
-96% -$387 ﹤0.01% 4050
2026
Q1
$364 Buy
276
+176
+176% +$315 ﹤0.01% 3878
2025
Q4
$187 Sell
100
-3,900
-98% -$7.49K ﹤0.01% 3812
2025
Q3
$5.12K Buy
4,000
+3,995
+79,900% +$5.41K ﹤0.01% 3137
2025
Q2
$6 Buy
+5
New +$6 ﹤0.01% 3638
2025
Q1
– Sell
-20
Closed -$37 – 3873
2024
Q4
$37 Hold
20
– – ﹤0.01% 3525
2024
Q3
$34 Hold
20
– – ﹤0.01% 3536
2024
Q2
$27 Hold
20
– – ﹤0.01% 3444
2024
Q1
$75 Hold
20
– – ﹤0.01% 3449
2023
Q4
$196 Hold
20
– – ﹤0.01% 3350
2023
Q3
$167 Sell
20
-80
-80% -$914 ﹤0.01% 3188
2023
Q2
$1.32K Buy
100
+80
+400% +$972 ﹤0.01% 3053
2023
Q1
$232 Sell
20
-60
-75% -$597 ﹤0.01% 3177
2022
Q4
$650 Buy
+80
New +$689 ﹤0.01% 3098
2022
Q3
– Sell
-5
Closed – – 3313
2022
Q2
$0 Buy
+5
New +$30 ﹤0.01% 3393
2021
Q3
– Sell
-550
Closed -$19K – 3156
2021
Q2
$19K Buy
+550
New +$16K ﹤0.01% 2214
2016
Q2
– Sell
-15,601
Closed -$133K – 2201
2016
Q1
$133K Sell
15,601
-4,399
-22% -$43.3K ﹤0.01% 638
2015
Q4
$263K Hold
20,000
– – 0.01% 468
2015
Q3
$73K Hold
20,000
– – ﹤0.01% 642
2015
Q2
$115K Buy
+20,000
New +$116K ﹤0.01% 520

Other funds holding PACB

Northwestern Mutual Wealth Management's PACB Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Pacific Biosciences (PACB) stake by 96% in Q2 2026, selling an estimated $387 and leaving 10 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #4050.

Northwestern Mutual Wealth Management first reported a position in PACB in Q2 2015 and has held it in 20 quarters since. The position peaked at $263K in Q4 2015. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Northwestern Mutual Wealth Management held 10 shares of Pacific Biosciences worth $17 as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 266 Pacific Biosciences shares in Q2 2026, an estimated $387.
  • Pacific Biosciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4050 holding.
  • Northwestern Mutual Wealth Management first reported a position in Pacific Biosciences in Q2 2015 and has held it in 20 quarters since.
  • Northwestern Mutual Wealth Management's Pacific Biosciences position peaked at $263K in Q4 2015.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.